BeiGene Ltd. Statistics
Share Statistics
BeiGene Ltd. has 114.55M shares outstanding. The number of shares has increased by 5.57% in one year.
| Shares Outstanding | 114.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.24% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 115.27M |
| Failed to Deliver (FTD) Shares | 10.77K |
| FTD / Avg. Volume | 2.91% |
Short Selling Information
The latest short interest is 1.09M, so 0.97% of the outstanding shares have been sold short.
| Short Interest | 1.09M |
| Short % of Shares Out | 0.97% |
| Short % of Float | 0.99% |
| Short Ratio (days to cover) | 2.93 |
Valuation Ratios
The PE ratio is -21.35 and the forward PE ratio is -150.11.
| PE Ratio | -21.35 |
| Forward PE | -150.11 |
| PS Ratio | 7.66 |
| Forward PS | 4.5 |
| PB Ratio | 5.32 |
| P/FCF Ratio | -10.83 |
| PEG Ratio | n/a |
Enterprise Valuation
BeiGene Ltd. has an Enterprise Value (EV) of 16.57B.
| EV / Earnings | -18.8 |
| EV / Sales | 6.74 |
| EV / EBITDA | -14.74 |
| EV / EBIT | -13.72 |
| EV / FCF | -9.53 |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.32 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.26 |
| Total Debt / Capitalization | 20.42 |
| Cash Flow / Debt | -1.27 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.25% and return on capital (ROIC) is -28.86%.
| Return on Equity (ROE) | -0.25% |
| Return on Assets (ROA) | -0.15% |
| Return on Capital (ROIC) | -28.86% |
| Revenue Per Employee | 231.96K |
| Profits Per Employee | -83.18K |
| Employee Count | 10.60K |
| Asset Turnover | 0.42 |
| Inventory Turnover | 0.91 |
Taxes
| Income Tax | 55.87M |
| Effective Tax Rate | -0.07 |
Stock Price Statistics
The stock price has increased by -2.15% in the last 52 weeks. The beta is 0.63, so BeiGene Ltd.'s price volatility has been higher than the market average.
| Beta | 0.63 |
| 52-Week Price Change | -2.15% |
| 50-Day Moving Average | 209.11 |
| 200-Day Moving Average | 177.84 |
| Relative Strength Index (RSI) | 35.53 |
| Average Volume (20 Days) | 370.58K |
Income Statement
In the last 12 months, BeiGene Ltd. had revenue of $2.46B and earned -$881.71M in profits. Earnings per share was $-8.45.
| Revenue | 2.46B |
| Gross Profit | 2.08B |
| Operating Income | -1.21B |
| Net Income | -881.71M |
| EBITDA | -1.12B |
| EBIT | -1.21B |
| Earnings Per Share (EPS) | -8.45 |
Balance Sheet
The company has $3.17B in cash and $930.18M in debt, giving a net cash position of $2.24B.
| Cash & Cash Equivalents | 3.17B |
| Total Debt | 930.18M |
| Net Cash | 2.24B |
| Retained Earnings | -7.96B |
| Total Assets | 5.83B |
| Working Capital | 1.89B |
Cash Flow
In the last 12 months, operating cash flow was -$1.16B and capital expenditures -$581.26M, giving a free cash flow of -$1.74B.
| Operating Cash Flow | -1.16B |
| Capital Expenditures | -581.26M |
| Free Cash Flow | -1.74B |
| FCF Per Share | -16.66 |
Margins
Gross margin is 84.55%, with operating and profit margins of -49.12% and -35.86%.
| Gross Margin | 84.55% |
| Operating Margin | -49.12% |
| Pretax Margin | -33.59% |
| Profit Margin | -35.86% |
| EBITDA Margin | -45.74% |
| EBIT Margin | -49.12% |
| FCF Margin | -70.71% |
Dividends & Yields
BGNE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4.72% |
| FCF Yield | -8.47% |
Analyst Forecast
The average price target for BGNE is $274, which is 53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $274 |
| Price Target Difference | 53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 3.72 |
| Piotroski F-Score | 3 |